Dry Eye Disease

Erscheinungsjahr 2022
ISBN: 978-0-323-82753-9
Verlag: Elsevier - Health Sciences Division

Buch, Englisch, 258 Seiten, Format (B × H): 236 mm x 191 mm, Gewicht: 552 g

Clinically-oriented and up-to-date, Dry Eye Diseases focuses on the latest diagnostic techniques, management guidelines, and treatment options for dry eye disorders. This consolidated resource provides guidance on the clinical assessment of patients presenting with dry eye symptoms as well as a global perspectives on the use of FDA and off-label products. Practicing and trainee ophthalmologists and optometrists will find this an indispensable resource for understanding this complex disorder. -

Covers a range of topics, including clinical assessment, pathophysiology, the link between dry eye and system disease, and the use of FDA and off-label products as treatment options for dry eye diseases.

-

Includes a section devoted to the presence of dry eye disease in specific populations, including patients presenting with other ocular conditions, systemic pain conditions, graft-versus-host disease, Sjögren's syndrome, and meibomian gland dysfunction.

-

Addresses the challenges associated with treating ocular pain not responsive to traditional dry eye disease treatments.

-

Features concise chapters from a team of international chapter authors, providing global perspectives on this common disorder.

-

Consolidates today's available information on this timely topic into a single, convenient resource

Autoren/Hrsg.

Galor, Anat

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Augenheilkunde, Optometrie

Inhaltsverzeichnis

Section 1: What is Dry Eye Disease (DED)?

1

What is Dry Eye Disease: Evolving Definitions and Epidemiology

2

Questionnaires Used to Assess Dry Eye Disease

3

Clinical Assessment of Dry Eye Disease: Tear Film and Ocular Surface Health

4

Clinical Assessment of Dry Eye Disease: Nerve Health

5

Pathophsiology of Dry Eye Disease using Animal Models

6

Pathophsiology of Dry Eye Disease using Human Models

Section 2: Dry Eye Disease (DED) in Specific Populations

7

Sjögrens and Dry Eye Disease

8

Graft versus Host and Dry Eye Disease

9

Meibomian Gland Dysfunction and Dry Eye Disease

10

Systemic Pain Conditions and Dry Eye Disease

11

Ocular Conditions and Dry Eye Disease

Section 3: Treatment of Dry Eye Disease (DEF)

12

Treatment of Dry Eye Disease in the United States

13

Treatment of Dry Eye Disease in Asia

14

Treatment of Dry Eye Disease in Europe

15

Treatment of Ocular Pain Not Responsive to Traditional Dry Eye Disease Treatments

Über Autor(innen)

Galor, Anat
Anat Galor is a staff physician at the Miami VAMC and a Professor of Ophthalmology at the Bascom Palmer Eye Institute, University of Miami. Dr. Galor received an undergraduate degree from Carnegie Mellon University in 1997 and a medical doctorate degree at Washington University School of Medicine in 2002. She pursued residency training in ophthalmology at the Cleveland Cole Eye Institute (2006) followed by fellowship training in uveitis at the Wilmer Eye Institute, Johns Hopkins University (2007) and fellowship training in cornea, external disease, and refractive surgery at the Bascom Palmer Eye Institute (2008).

Dr. Galor is the author of numerous publications that focus on dry eye, ocular surface tumors, and cornea. Dr. Galor's research has focused on understanding mechanisms of pain in dry eye, with an emphasis on studying new diagnostic and treatment modalities.